GlassScriptPhysician profile
Andrew D Breithaupt
NPI 1437460359
$10,757.27
in general payments reported to CMS, 2019-2025
35 companies · $678 in 2025
The $678 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,289 · 2020: $235 · 2021: $207 · 2022: $3,832 · 2023: $664 · 2024: $853 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $3,496.65 | 2019-2024 | Libtayo, Dupixent |
| Genzyme Corporation | $2,933.56 | 2019-2025 | |
| Abbvie INC. | $1,116.27 | 2019-2025 | Rinvoq, Skyrizi |
| Biofrontera INC. | $567.51 | 2019-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Incyte Corporation | $363.09 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $342.42 | 2022-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $217.36 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $215.06 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $197.07 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $148.38 | 2019-2024 | Adbry |
| Almirall LLC | $119.12 | 2019-2022 | |
| Ucb, INC. | $116.35 | 2019-2024 | Bimzelx |
| Organogenesis INC. | $108.67 | 2025 | Via Matrix, Puraply Wound Matrix, Novachor |
| Fresenius Kabi USA, LLC | $74.92 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $66.82 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glenmark Therapeutics INC. | $60.00 | 2019 | |
| Amgen INC. | $58.19 | 2024 | Otezla |
| Lilly USA, LLC | $53.19 | 2019-2024 | Taltz, Zepbound |
| Verrica Pharmaceuticals INC. | $47.67 | 2023-2024 | Ycanth |
| Celgene Corporation | $47.26 | 2019 | |
| Smith+Nephew, INC. | $46.95 | 2025 | Grafix Pl |
| Sandoz INC. | $45.79 | 2019 | |
| Genentech USA, INC. | $43.44 | 2019 | |
| Vyne Pharmaceuticals INC. | $36.20 | 2021 | |
| Krystal Biotech INC | $32.32 | 2024 | Vyjuvek |
| Surgenex LLC | $23.95 | 2025 | Ardeograft, Surgraft, Surmatrix |
| Prugen, INC. Pharmaceuticals | $23.38 | 2019 | |
| Blueprint Medicines Corporation | $23.18 | 2024 | Ayvakit |
| Dusa Pharmaceuticals, INC. | $23.05 | 2019 | |
| Kyowa Kirin, INC. | $19.69 | 2022 | |
| Galderma Laboratories, L.P. | $19.35 | 2023 | |
| Aclaris Therapeutics, INC. | $19.13 | 2019 | |
| Pfizer INC. | $18.98 | 2023 | |
| Epi Health, LLC | $18.50 | 2019 | |
| Tactile Systems Technology INC | $13.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Breithaupt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.